DK176121B1 - Farmaceutisk præparat indeholdende 1-isobutyl-1H-imidazol[4,5-c]-quinolin-4-amin - Google Patents

Farmaceutisk præparat indeholdende 1-isobutyl-1H-imidazol[4,5-c]-quinolin-4-amin Download PDF

Info

Publication number
DK176121B1
DK176121B1 DK198906138A DK613889A DK176121B1 DK 176121 B1 DK176121 B1 DK 176121B1 DK 198906138 A DK198906138 A DK 198906138A DK 613889 A DK613889 A DK 613889A DK 176121 B1 DK176121 B1 DK 176121B1
Authority
DK
Denmark
Prior art keywords
approx
weight
amine
composition
isobutyl
Prior art date
Application number
DK198906138A
Other languages
Danish (da)
English (en)
Other versions
DK613889A (da
DK613889D0 (da
Inventor
Steven Marshall Wick
Helen Jensen Schultz
Gregory Roy Nelson
Amit Kumar Mitra
Stephen Michael Berge
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of DK613889D0 publication Critical patent/DK613889D0/da
Publication of DK613889A publication Critical patent/DK613889A/da
Application granted granted Critical
Publication of DK176121B1 publication Critical patent/DK176121B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK198906138A 1988-12-15 1989-12-06 Farmaceutisk præparat indeholdende 1-isobutyl-1H-imidazol[4,5-c]-quinolin-4-amin DK176121B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28493388A 1988-12-15 1988-12-15
US28493388 1988-12-15

Publications (3)

Publication Number Publication Date
DK613889D0 DK613889D0 (da) 1989-12-06
DK613889A DK613889A (da) 1990-06-16
DK176121B1 true DK176121B1 (da) 2006-09-11

Family

ID=23092090

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198906138A DK176121B1 (da) 1988-12-15 1989-12-06 Farmaceutisk præparat indeholdende 1-isobutyl-1H-imidazol[4,5-c]-quinolin-4-amin

Country Status (14)

Country Link
EP (1) EP0376534B1 (ko)
JP (1) JP2915034B2 (ko)
KR (1) KR0150445B1 (ko)
AU (1) AU631585B2 (ko)
CA (1) CA2004597C (ko)
DE (2) DE68911499T2 (ko)
DK (1) DK176121B1 (ko)
ES (1) ES2062043T3 (ko)
HK (1) HK1006275A1 (ko)
IE (1) IE62569B1 (ko)
IL (1) IL92537A (ko)
NL (1) NL980042I1 (ko)
NZ (1) NZ231655A (ko)
ZA (1) ZA899450B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232740A (en) * 1989-04-20 1992-06-25 Riker Laboratories Inc Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
KR960703621A (ko) * 1993-08-10 1996-08-31 후지야마 아키라 경피흡수 제제(Percutaneously absorbable preparation)
DE4434775A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
NZ512628A (en) * 1999-01-08 2004-03-26 3M Innovative Properties Co Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
WO2002092070A1 (en) * 2001-05-11 2002-11-21 Elan Corporation, Plc Isostearic acid salts as permeation enhancers
EP1390383B1 (en) 2001-05-11 2012-02-29 Isis Pharmaceuticals, Inc. Antisense permeation enhancers
CN1292751C (zh) * 2002-04-23 2007-01-03 四川大学 皮肤局部用咪喹莫特或其衍生物脂质体及其制备方法和用途
CN100558361C (zh) 2003-03-13 2009-11-11 3M创新有限公司 改善皮肤质量的方法
EP2526950A1 (en) 2006-04-07 2012-11-28 Merrion Research III Limited Solid oral dosage form containing an enhancer
US9023863B2 (en) 2006-07-14 2015-05-05 Stiefel Research Australia Pty Ltd Fatty acid pharmaceutical foam
EP1889609B1 (en) * 2006-07-18 2019-05-22 Meda AB Immune response modifier foam formulations
KR20110007614A (ko) 2008-05-07 2011-01-24 메리온 리서치 Ⅲ 리미티드 ＧｎＲＨ 관련 화합물의 조성물 및 제조 방법
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
CN103476419A (zh) 2011-01-07 2013-12-25 梅里翁第三研究有限公司 口服投药的含铁药物组合物
EP3250191B1 (en) 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating
ES2940736B2 (es) 2021-11-09 2023-09-19 Ntd Labs S L U Uso combinado de imiquimod y de un hidrolizado de caseina para el tratamiento de condilomas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
CA1272445A (en) * 1985-02-25 1990-08-07 Yie W. Chien Transdermal pharmaceutical absorption dosage unit and process of pharmaceutical administration
CA1288698C (en) * 1985-08-30 1991-09-10 Yie W. Chien Transdermal anti-anginal pharmaceutical dosage

Also Published As

Publication number Publication date
ES2062043T3 (es) 1994-12-16
JP2915034B2 (ja) 1999-07-05
KR900009084A (ko) 1990-07-02
KR0150445B1 (ko) 1998-10-15
CA2004597A1 (en) 1990-06-15
ZA899450B (en) 1990-09-26
IE62569B1 (en) 1995-02-08
DE68911499D1 (de) 1994-01-27
IL92537A0 (en) 1990-08-31
AU4670689A (en) 1990-06-21
HK1006275A1 (en) 1999-02-19
AU631585B2 (en) 1992-12-03
CA2004597C (en) 2000-02-08
DE19975026I2 (de) 2010-07-08
IE893888L (en) 1990-06-15
DK613889A (da) 1990-06-16
IL92537A (en) 1994-04-12
DE68911499T2 (de) 1994-06-30
JPH02282327A (ja) 1990-11-19
DK613889D0 (da) 1989-12-06
EP0376534A1 (en) 1990-07-04
NZ231655A (en) 1992-06-25
EP0376534B1 (en) 1993-12-15
NL980042I1 (nl) 1999-02-01

Similar Documents

Publication Publication Date Title
DK176121B1 (da) Farmaceutisk præparat indeholdende 1-isobutyl-1H-imidazol[4,5-c]-quinolin-4-amin
US5238944A (en) Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
US5736553A (en) Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine
US5164189A (en) Single layer transdermal drug administration system
EP2062575B1 (en) Adhesive preparation comprising desglymidodrine
JP2931002B2 (ja) 皮膚透過エストラジオールデリバリーシステム
JPH0372416A (ja) 経皮用製剤
US11202752B2 (en) Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
US9271973B2 (en) Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
JP2003533434A (ja) 改良された経皮的避妊薬送達系および方法
KR19980701730A (ko) 경피 투여용 제제
KR20050111317A (ko) 혈소판혈병의 치료를 위한 제형 및 방법
CA2394471C (en) External preparation for treating pruritus
EP2062576B1 (en) Adhesive preparation comprising desglymidodrine
JP3618970B2 (ja) 貼付剤
TWI309982B (en) Transdermal administration of ace inhibitors
JPH06135828A (ja) 経皮吸収性製剤
KR20080006960A (ko) 소수성 비스테로이드성 소염진통제를 함유하는 경피 투여제제
CN1633995A (zh) 一种透皮避孕药传送体系及方法
Bierman et al. Transdermal Controlled Delivery of Drugs With Special Reference to Development and Evaluation of Transdermal Contraceptive Devices YW Chien, Ph. D., TY Chien, Ph. D., YC Huang, Ph. D.

Legal Events

Date Code Title Description
PUP Patent expired